sertraline has been researched along with Parkinson Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duval, F; Flabeau, O; Razafimahefa, J; Spampinato, U; Tison, F | 1 |
| García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B | 1 |
| Antonini, A | 1 |
| Alagna, A; Bramanti, P; Di Bella, P; Di Lorenzo, G; Digangi, G; Marino, S; Sessa, E | 1 |
| Barone, P | 1 |
| Heilman, KM; Okun, MS; Vitek, JL | 1 |
| Leentjens, AF; Luijckx, GJ; Verhey, FR; Vreeling, FW | 1 |
| Antonini, A; Barone, P; Bracco, F; Marconi, R; Morgante, L; Musch, B; Scarzella, L; Zappia, M | 1 |
| Antonini, A; Barone, P; Canesi, M; De Gaspari, D; Mariani, C; Meucci, N; Pezzoli, G; Sacilotto, G; Tesei, S; Zecchinelli, A | 1 |
| Iacono, RP; Toyama, SC | 1 |
| Olanow, CW | 1 |
| Hayes, HD | 1 |
| Dike, GL | 1 |
| Hauser, RA; Zesiewicz, TA | 1 |
| Hobson, P; Meara, J | 1 |
1 review(s) available for sertraline and Parkinson Disease
| Article | Year |
|---|---|
Treatment of depressive symptoms in Parkinson's disease.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Depression; Desipramine; Dopamine Agonists; Humans; Levodopa; Nortriptyline; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
6 trial(s) available for sertraline and Parkinson Disease
| Article | Year |
|---|---|
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index | 2008 |
Sertraline in the treatment of depressive disorders in patients with Parkinson's disease.
Topics: Aged; Brain; Brain Chemistry; Deglutition Disorders; Depressive Disorder; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2008 |
SSRIs in the treatment of depression in Parkinson's disease.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 2006 |
Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.
Topics: Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 2006 |
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
8 other study(ies) available for sertraline and Parkinson Disease
| Article | Year |
|---|---|
Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
Topics: Aged; Akathisia, Drug-Induced; Antiparkinson Agents; Brain Diseases; Delusions; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Indans; Myoclonus; Neuroprotective Agents; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2013 |
Unraveling depression in Parkinson's disease.
Topics: Antidepressive Agents; Benzothiazoles; Clinical Trials as Topic; Cohort Studies; Depression; Depressive Disorder; Dopamine; Dopamine Agonists; Drug Interactions; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Quality of Life; Serotonin; Sertraline | 2008 |
Treatment of pseudobulbar laughter after gamma knife thalamotomy.
Topics: Humans; Laughter; Male; Middle Aged; Parkinson Disease; Pseudobulbar Palsy; Radiosurgery; Selective Serotonin Reuptake Inhibitors; Sertraline; Thalamic Nuclei | 2002 |
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1994 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E | 1996 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antidepressive Agents; Antiparkinson Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1996 |
Triphasic waves in serotonin syndrome.
Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome | 1997 |
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents; Depressive Disorder; Humans; Parkinson Disease; Personality Assessment; Sertraline; Treatment Outcome | 1998 |